Skip to content Skip to navigation
National Cancer Data Base - Data Dictionary PUF 2014

Systemic Surgery Sequence

DD_category: 
PUF Data Item Name: 
RX_SUMM_SYSTEMIC_SUR_SEQ
NAACCR Item #: 
1639
length: 
1
Allowable values: 
0, 2-6, 9
Description: 
Records the sequencing of systemic treatment and surgical procedures given as part of the first course of treatment.
Registry Coding Instructions: 

Surgical procedures include Surgical Procedures of the Primary Site (NAACCR Item #1290, Scope of Regional Lymph Node Surgery (NAACCR Item #1292), and Surgical Procedure/Other Site (NAACCR Item #1294).  Systemic therapy includes Chemotherapy (NAACCR Item #1390), Hormone Therapy (NAACCR Item #1300), Immunotherapy (NAACCR Item #1410) and Hematologic Transplant and Endocrine Procedure (NAACCR Item #3250).  If no surgical procedure was performed, or no systemic treatment was given, this item is coded 0.
 
If both surgery and systemic treatment were provided for this cancer, then code 2-9, as appropriate.

Analytic Note: 

This item was added to FORDS for use with cases diagnosed in 2006 or later. 
 
CoC cancer programs are required to identify treatment their patients received from all sources.  Treatment may have occurred at any facility, or at multiple facilities, not limited to the one whose report is included in this file. 

Code Definition

0   

No systemic therapy was given; and/or no surgical procedure of primary site; no scope of regional lymph node surgery; no surgery to other regional site(s), distant site(s), or distant lymph node(s); or no reconstructive surgery was performed. Or: It is unknown whether both surgery and systemic treatment were provided.

2

Systemic therapy was given before surgical procedure of primary site; scope of regional lymph node surgery; surgery to other regional site(s), distant site(s), or distant lymph node(s) was performed.

3

Systemic therapy was given after surgical procedure of primary site; scope of regional lymph node surgery; surgery to other regional site(s), distant site(s), or distant lymph node(s) was performed.

4

At least two courses of systemic therapy were given before and at least two more after a surgical procedure of primary site; scope of regional lymph node sugery; surgery to other regional site(s), or distant site(s), or lymph node(s) was performed.

5

Intraoperative systemic therapy was given during surgical procedure of primary site; scope of regional lymph node surgery; surgery to other regional site(s), distant site(s), or distant lymph node(s).

6

Intraoperative systemic therapy was given during surgical procedure of primary site; scope of regional lymph node surgery; surgery to other regional site(s), distant site(s), or distant lymph node(s) with other systemic therapy administered before or after surgical procedure of primary site; scope of regional lymph node surgery; surgery to other regional site(s), distant site(s), or distant lymph node(s) was performed.

7

Systemic therapy was administered between two separate surgical procedures to the primary site; regional lymph node surgery; surgery to other regional site(s), distant site(s), or distant lymph node(s) with other systemic therapy adminstered before or after surgical procedures to the primary site; regional lymph node surgery; surgery to other regional site(s), distant site(s), or distant lymph node(s) was performed.

9

Both surgery and systemic therapy were provided, but the sequence is unknown.